No Prescription |
 |
 | ||
|
Beconase Hayfever Generic Beclomethasone Dipropionate |
|
| ||
No Prescription » Prescription Drugs 2 » Beconase Hayfever Generic Beclomethasone Dipropionate The medicine in your Beconase Hayfever is called beclomethasone dipropionate. This is one of a group of medicines known as corticosteroids frequently called "steroids". They are not "anabolic steroids" which are the steroids sometimes misused by athletes.Beconase Hayfever helps to prevent and treat allergic rhinitis (including hay fever) and related conditions. Allergic rhinitis includes symptoms such as an itchy sensation in the nose throat and eyes followed by sneezing stuffiness runny nose and often watery eyes.Beconase Hayfever works by reducing the swelling and irritation in the lining of the nose. It relieves the symptoms of blocked nose runny nose itchy nose and sneezing.It usually takes a few days for this medicine to help your nasal symptoms.You may know that you are going to be allergic to for example pollen at a particular time of year. It is helpful to start using your spray just before your symptoms appear to prevent them from starting. If you already have symptoms improvement in your condition will take a few days.If you have itchy eyes tell your doctor or pharmacist. They may tell you to use additional medicine to treat your eye symptoms. Buy Beconase Hayfever Generic Beclomethasone Dipropionate and other Prescription Drugs 2 products online at Medstore. Buy Online at Medstore - Click Here!
About Beconase Hayfever Generic Beclomethasone Dipropionate: Product Type: Prescription Drugs 2 Beconase Hayfever ( Generic Beclomethasone Dipropionate ) Beconase Hayfever (Generic Beclomethasone Dipropionate) Generic Beclomethasone Dipropionate 50mcg 200 dose 3 x 200 dose Generic Beclomethasone Dipropionate Beconase Hayfever
View more Prescription Drugs 2 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
